Ignacio Melero
- Immunology top 0.02%
- Immunotherapy and Immune Responses 180
- Immune Cell Function and Interaction 112
- T-cell and B-cell Immunology 62
- Oncology top 0.02%
- Cancer Immunotherapy and Biomarkers 153
- CAR-T cell therapy research 132
- Hepatology top 0.2%
- Hepatocellular Carcinoma Treatment and Prognosis 28
- Cancer Research top 0.5%
- Biotechnology top 0.2%
-
- Virus-based gene therapy research 40
-
- Monoclonal and Polyclonal Antibodies Research 26
- Co-authors
- José Luis Perez‐GraciaBruno SangroMiguel F. SanmamedMaría E. Rodríguez-RuizSandra Hervás‐StubbsJesús PrìetoDavid SanchoLieping Chen
- Cited by
- ImmunologyOncologyHepatology
- Journals
- Journal of Clinical Oncology (40 papers)Annals of Oncology (35 papers)Journal for ImmunoTherapy of Cancer (28 papers)
- Partner nations
- SpainUnited StatesUnited Kingdom
In The Last Decade
Ignacio Melero
384 papers receiving 27.8k citations
Hit Papers
Peers
Comparison fields: 5 of 156
- Immunology 16.8k
- Oncology 15.8k
- Hepatology 2.3k
- Cancer Research 2.4k
- Biotechnology 982
Countries citing papers authored by Ignacio Melero
This map shows the geographic impact of Ignacio Melero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ignacio Melero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ignacio Melero more than expected).
Fields of papers citing papers by Ignacio Melero
This network shows the impact of papers produced by Ignacio Melero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ignacio Melero. The network helps show where Ignacio Melero may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Ignacio Melero, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | Immunotherapy in Non–Small Cell Lung Cancer: Facts and Hopesbreakdown → | 2019 | 470 |
| 3 | 2018 | 65 | |
| 4 | 2018 | 69 | |
| 5 | 2017 | 190 | |
| 6 | 2017 | 35 | |
| 7 | 2016 | 198 | |
| 8 | 2016 | 316 | |
| 9 | Results from an Integrated Safety Analysis of Urelumab, an Agonist Anti-CD137 Monoclonal Antibodybreakdown → | 2016 | 281 |
| 10 | 2015 | 362 | |
| 11 | 2015 | 129 | |
| 12 | 2015 | 81 | |
| 13 | 2015 | 89 | |
| 14 | 2014 | 204 | |
| 15 | 2014 | 35 | |
| 16 | 2013 | 81 | |
| 17 | 2012 | 39 | |
| 18 | 2012 | 21 | |
| 19 | 2011 | 112 | |
| 20 | 2006 | 116 |
About Ignacio Melero
Ignacio Melero is a scholar working on Immunology, Oncology and Hepatology, having authored 396 papers that have together received 28.2k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (180 papers), Cancer Immunotherapy and Biomarkers (153 papers), CAR-T cell therapy research (132 papers), Immune Cell Function and Interaction (112 papers), T-cell and B-cell Immunology (62 papers), Virus-based gene therapy research (40 papers), Hepatocellular Carcinoma Treatment and Prognosis (28 papers) and Monoclonal and Polyclonal Antibodies Research (26 papers). The work is most often cited by research in Immunology (16.8k citations), Oncology (15.8k citations) and Hepatology (2.3k citations). Ignacio Melero has collaborated with scholars based in Spain, United States and United Kingdom. Frequent co-authors include José Luis Perez‐Gracia, Bruno Sangro, Miguel F. Sanmamed, María E. Rodríguez-Ruiz, Sandra Hervás‐Stubbs, Jesús Prìeto, David Sancho, Lieping Chen, Francisco J. Cueto and Pedro Berraondo. Their work appears in journals such as Journal of Clinical Oncology, Annals of Oncology, Journal for ImmunoTherapy of Cancer, Cancer Research and Clinical Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.